Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-25 @ 7:14 PM
Study NCT ID:
NCT07192432
Status:
RECRUITING
Last Update Posted:
2025-10-10
First Post:
2025-09-17
Is Possible Gene Therapy:
True
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
Sponsor:
Vironexis Biotherapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11
Start Date Type:
ESTIMATED
Primary Completion Date:
2033-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-17
First Submit QC Date:
None
Study First Post Date:
2025-09-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED